Dialectical Behavioral Therapy in Adolescents With Suicidal Behaviors
NCT ID: NCT02406625
Last Updated: 2017-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2014-11-30
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For this reason, the investigators aimed to study the clinical, neuropsychological and neural effects of Dialectical Behavioral Therapy in adolescents with suicidal behaviors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collaborative Adolescent Research on Emotions and Suicide
NCT01528020
Effectiveness Study of a Dialectical Behavioral Treatment for Adolescents With Emotional Instability and Their Families
NCT02991586
Stratified-Care School-Based Intervention for Adolescent Suicidal Ideation
NCT07063914
An Autobiographical Memory-Based Intervention for Suicidality
NCT06225531
DBT Skills Expanded With Contextual Intervention for Long Lasting Symptoms in Borderline Personality Disorder
NCT05972096
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators hypothesis is that DBT (Dialectical Behavioral Therapy) will improve clinical symptoms associated with suicidal behaviors, as well as the neural interconnections, which will result not only in structural and functional connectivity changes, but also in a better cognitive functioning. The investigators aimed to investigate the clinical, neuropsychological, and neural effects of Dialectical Behavioral Therapy in adolescents with suicidal behaviors.
The investigators method is a randomized, controlled study that includes 30 patients with suicidal behaviors and 15 healthy controls between the ages of 12 and 18 years. Patients were assigned to one of two groups (randomized): DBT and Regular Support Therapy. Clinical and neuropsychological evaluations were performed before and after the treatment for both patient groups. Additionally, Structural MRI data sets, diffusion-tensor imaging (DTI) and Functional Connectivity (Resting State fmri) were acquired for all patients and controls at baseline and after treatment. Initial characteristics will be compared between the three groups, and the investigators will also compared clinical, neuropsychological and imaging measures before and after the treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diaclectical Behavioral Therapy
15 adolescents with history of suicidal behaviors receiving Dialectical Behavioral Therapy.
Behavioral Therapy
16 therapeutic group sessions are delivered to both parents and adolescents; according to the assigned group for each family.
Support Therapy
15 adolescents with history of suicidal behaviors receiving Support Therapy.
Behavioral Therapy
16 therapeutic group sessions are delivered to both parents and adolescents; according to the assigned group for each family.
Controls
A group of 15 healthy controls that are not receiving any kind of therapy.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Therapy
16 therapeutic group sessions are delivered to both parents and adolescents; according to the assigned group for each family.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intellectual level over 70 (IQ\>70)
* For the experimental groups:
* Patients with suicidal behavior:
* Real attempt,
* Interrupted attempt,
* Aborted attempt or behaviors, or
* Preparation actions (based on the Columbia Suicide Severity Rating Scale -C-SSRS criteria) present during the last 12 months and that persist in the actual moment.
Exclusion Criteria
* Eating Disorder with an BMI \< 18.5;
* Substance abuse in the current moment or during the last 6 months;
* Any neurological condition that curses with cognitive alterations; and
* Pregnancy.
12 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Santamarina Pérez, Pilar
UNKNOWN
Romero Cela, María Soledad
UNKNOWN
Méndez Blanco, Iria
UNKNOWN
Font, Elena
UNKNOWN
Fundacion Clinic per a la Recerca Biomédica
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marisol Picado Rossi
Ph.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clínic
Barcelona, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Interventions for self-harm in children and adolescents. Cochrane Database Syst Rev. 2021 Mar 7;3(3):CD013667. doi: 10.1002/14651858.CD013667.pub2.
Santamarina-Perez P, Mendez I, Singh MK, Berk M, Picado M, Font E, Moreno E, Martinez E, Morer A, Borras R, Cosi A, Romero S. Adapted Dialectical Behavior Therapy for Adolescents with a High Risk of Suicide in a Community Clinic: A Pragmatic Randomized Controlled Trial. Suicide Life Threat Behav. 2020 Jun;50(3):652-667. doi: 10.1111/sltb.12612. Epub 2020 Jan 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DBT001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.